Locations:
Search IconSearch

Neurosciences

22-NEU-2635109_postacute-rehab-at-home_650x450
January 24, 2022/Neurosciences/PM&R

High-Intensity Home-Based Rehabilitation Offers Alternative to Skilled Nursing Facility

Innovative postacute care model reduces costs, improves functional outcomes

22-NEU-2631258-CQD-Hero-650×450
January 19, 2022/Genomic Medicine

Launch of Cleveland Clinic Brain Study Marks Unprecedented Effort to Disrupt Neurological Diseases

First-of-kind study aims to enable prevention of brain disorders before symptoms appear

Medications in the ICU. Medicinal lines next to patient bed
January 14, 2022/Neurosciences/Epilepsy

Continuous EEG in Critically Ill Patients: Study Raises Reasons to Revisit Monitoring Duration

Consider 36-hour standard, with certain risk factors prompting longer or shorter windows

Acupuncture
December 30, 2021/Neurosciences

Noninvasive Treatments for Chronic Neck and Back Pain

Alternative treatments for chronic pain are effective and available, but physicians don't always turn to them as first-line options

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Glioblastoma

Failed Alzheimer’s Drug Shows Promise for Treating Glioblastoma in Preclinical Study

BACE1 inhibitor reduces cancer progression in models of glioblastoma

21-NEU-2526665_T-cell-activation_650x450

Antibody-Mediated Autoimmune Encephalitis: A Practical Approach to Diagnosis and Management

Objective clinical and radiographic findings are central to optimal outcomes

Genetics brain concept
December 17, 2021/Genomic Medicine

The Promise of Gene Therapy in Neurological Disorders (Podcast)

Advanced genomic research techniques show potential to treat a variety of conditions

21-NEU-2527887-CQD-Hero-2-650×450 (1)

Transient Neurological Symptoms in the Lead-Up to Redo Aortic Valve Replacement: A Case Study

A perplexing presentation underscores the value of broadly collaborative care

21-NEU-2568466-CQD-Hero-2-650×450

Sildenafil Emerges as a Candidate Drug for Alzheimer’s Disease

69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies

BackPage 35 of 89Next

Advertisement

Ad